New drug trial aims to block sickle Cell's agonizing pain crises
NCT ID NCT05075824
Summary
This study is testing whether a new drug called crovalimab, when added to a patient's usual sickle cell treatments, can help prevent the severe pain episodes known as vaso-occlusive crises. It will involve about 90 participants with sickle cell disease who have experienced several pain crises in the past year. The main goal is to see if the drug safely reduces the number of these painful episodes requiring medical care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Adana Acibadem Hospital; Pediatric Hematology
Adana, 01130, Turkey (Türkiye)
-
Amsterdam UMC Location VUMC
Amsterdam, 1081 HV, Netherlands
-
Azienda Ospedaliera di Verona-Policlinico G.B. Rossi
Verona, Veneto, 37134, Italy
-
Beneficencia Portuguesa de Sao Paulo
São Paulo, São Paulo, 01323-900, Brazil
-
CHU Henri Mondor
Créteil, 64010, France
-
Central Middlesex Hospital
London, NW10 7NS, United Kingdom
-
Charlotte Maxeke Johannesburg Hospital
Johannesburg, 2193, South Africa
-
Children's Hospital of Michigan
Detroit, Michigan, 48201, United States
-
Cukurova University Medical Faculty Balcali Hospital
Adana, 1330, Turkey (Türkiye)
-
East Carolina University
Greenville, North Carolina, 27834, United States
-
Gertrude's Children Hospital
Nairobi, Kenya
-
HEMORIO
Rio de Janeiro, 20211-030, Brazil
-
Hammersmith Hospital
London, W12 0HS, United Kingdom
-
Hopital Nini
Tripoli, Lebanon
-
Hospital General Univ. Gregorio Maranon
Madrid, 28009, Spain
-
Hospital Samaritano
São Paulo, 01232-010, Brazil
-
Hospital Sao Rafael - HSR
Salvador, Estado de Bahia, 41253-190, Brazil
-
Hospital Universitario Miguel Servet
Zaragoza, 50009, Spain
-
Hospital das Clinicas - UFRGS
Porto Alegre, Rio Grande do Sul, Brazil
-
Hospital das Clínicas Faculdades Médicas de Ribeirão Preto
Ribeirão Preto, São Paulo, 14051-140, Brazil
-
Hospital de Base de Sao Jose do Rio Preto
São José do Rio Preto, São Paulo, 15090-000, Brazil
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
International Cancer Institute (ICI)
Eldoret, 30100, Kenya
-
Mersin Universitesi Tip Fakultesi Hastanesi
Mersin, 33343, Turkey (Türkiye)
-
Mississippi Center for Advanced Medicine
Madison, Mississippi, 39110, United States
-
UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu
Botucatu, São Paulo, 18618-970, Brazil
-
Università degli Studi della Campania Luigi Vanvitelli
Napoli, Campania, 80138, Italy
Conditions
Explore the condition pages connected to this study.